Elsevier

Brain Research

Volume 492, Issues 1–2, 17 July 1989, Pages 15-28
Brain Research

Opiate antagonists and self-stimulation: extinction-like response patterns suggest selective reward deficit

https://doi.org/10.1016/0006-8993(89)90884-6Get rights and content

Abstract

The present study investigated the response decrement patterns produced by opiate antagonists on intracranial self-stimulation behavior, in order to determine if these drugs affect the reinforcement value of the stimulation or interface with the ability of the animal to respond. Male rats lever-pressed in 60-min sessions on a continuous reinforcement schedule for self-stimulation of the nucleus accumbens. Naloxone (2.0 and 20 mg/kg) and naltrexone (2.0 and 20 mg/kg) suppressed self-stimulation only after a significant delay, in an extinction-like response decrement pattern, mimicking the effects of reductions in current intensity (75% and 50% of baseline). The increasing behavioral effects characteristics of the extinction pattern were observed despite the fact that testing began after the time point at which maximal suppression of self-stimulation occurs with these drugs, and when brain concentrations of these drugs were declining. Since normal responding was observed for several minutes after the beginning of the session, the results may explain why long sessions are necessary to observe suppression of self-stimulation by opiate antagonists. The extinction-like pattern produced by these drugs suggests that opiate antagonists suppress self-stimulation by reducing the reinforcement value of the stimulation, rather than by interfering with the ability of the animal to respond. These findings are consistent with a role for endogenous opioid peptides in brain stimulation reward.

Reference (83)

  • FranklinK.B.J. et al.

    Effects and interactions of naloxone and amphetamine on self-stimulation of the prefrontal cortex and dorsal tegmentum

    Pharmacol. Biochem. Behav.

    (1982)
  • FreedmanN.L. et al.

    Site-specific naloxone blockade of brain self-stimulation duration

    Pharmacol. Biochem. Behav.

    (1984)
  • GallistelC.R. et al.

    Does pimozide block the reinforcing effect of brain stimulation?

    Pharmacol. Biochem. Behav.

    (1982)
  • GoedersN.E. et al.

    Self-administration of methionine enkephalin into the nucleus accumbens

    Pharmacol. Biochem. Behav.

    (1984)
  • GoldsteinJ.M. et al.

    Effect of substance P on medial forebrain bundle self-stimulation in rats following intracerebral administration

    Pharmacol. Biochem. Behav.

    (1977)
  • HaberS. et al.

    Naloxone blocks amphetamine-induced rearing: potential interaction between catecholamines and endorphins

    Prog. Neuropsychopharmacol.

    (1978)
  • HillR.G.

    The status of naloxone in the identification of pain control mechanisms operated by endogenous opioids

    Neurosci. Lett.

    (1981)
  • HoltzmanS.G.

    Effects of narcotic antagonists on fluid intake in the rat

    Life Sci.

    (1975)
  • IchitaniY. et al.

    Approach and escape responses to mesencephalic central gray stimulation in rats: effects of morphine and naloxone

    Behav. Brain Res.

    (1986)
  • IchitaniY. et al.

    Effects of naloxone and chlordiazepoxide on lateral hypothalamic self-stimulation in rats

    Physiol. Behav.

    (1985)
  • KamataK. et al.

    Antagonism of footshoch stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine

    Brain Research

    (1986)
  • KatzR.J.

    Identification of a novel class of central reward sites showing a delayed and cumulative response to opiate blockade

    Pharmacol. Biochem. Behav.

    (1981)
  • KelseyJ.E. et al.

    Does naloxone suppress self-stimulation by decreasing reward or increasing aversion?

    Brain Research

    (1984)
  • LiebmanJ.M.

    Discriminating between reward and performance: a critical review of intracranial self-stimulation strategy

    Neurosci. Biobehav. Rev.

    (1983)
  • LorensS.A. et al.

    Naloxone blocks the excitatory effect of ethanol and chlordiazepoxide on lateral hypothalamic self-stimulation behavior

    Life Sci.

    (1978)
  • NazzaroJ. et al.

    GABA antagonism lowers self-stimulation thresholds in the ventral tegmental area

    Brain Research

    (1980)
  • OldsM.E.

    Reinforcing effects of morphine in the nucleus accumbens

    Brain Research

    (1982)
  • PerryW. et al.

    Effects of chronic naloxone treatment on brain-stimulation reward

    Pharmacol. Biochem. Behav.

    (1981)
  • PotterC.D. et al.

    Opiate-receptor blockade reduces voluntary running but not self-stimulation in hamsters

    Pharmacol. Biochem. Behav.

    (1983)
  • ReymannK.G. et al.

    Opioid-receptor blockade reduces nose-poke self-stimulation derived from medial entorhinal cortex

    Pharmacol. Biochem. Behav.

    (1986)
  • SassonS. et al.

    Naloxone lowers brain-stimulation escape thresholds

    Pharmacol. Biochem. Behav.

    (1983)
  • SchaeferG.J. et al.

    Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats

    Pharmacol. Biochem. Behav.

    (1985)
  • SchaeferG.J. et al.

    Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed ratio schedule in rats

    Pharmacol. Biochem. Behav.

    (1988)
  • SchenkS. et al.

    Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation

    Pharmacol. Biochem. Behav.

    (1985)
  • SeegerT.F. et al.

    Pentobarbital induces a naloxone-reversible decrease in mesolimbic self-stimulation threshold

    Pharmacol. Biochem. Behav.

    (1981)
  • SteinE.A.

    Effects of intracranial self-stimulation on brain opioid peptides

    Peptides

    (1985)
  • TeppermanF.S. et al.

    Brain and serum levels of naloxone following peripheral administration

    Life Sci.

    (1983)
  • Van der KooyD. et al.

    Apparent independence of opiate reinforcement and electrical self-stimulation systems in rat brain

    Life Sci.

    (1977)
  • Van der KooyD. et al.

    Reinforcing effects of morphine revealed by conditioned place preference

    Brain Research

    (1982)
  • Van WolfswinkelL. et al.

    Long-term changes in self-stimulation threshold by repeated morphine and naloxone treatment

    Life Sci.

    (1985)
  • WestC.H.K. et al.

    Increasing the work requirements lowers the threshold of naloxone for reducing self-stimulation in the midbrain of rats

    Pharmacol. Biochem. Behav.

    (1983)
  • Cited by (24)

    • Reinforcement: Neurochemical Substrates

      2015, International Encyclopedia of the Social & Behavioral Sciences: Second Edition
    • Disruption of endogenous opioid activity during instrumental learning enhances habit acquisition

      2009, Neuroscience
      Citation Excerpt :

      Although it has long been thought that the endogenous opioid system is important for hedonic tone (Narayanan et al., 2004; Skoubis et al., 2005), here we show that opioid processes are critical for the acquisition of normal goal-directed control of actions. Indeed, blockade of opioid receptors acutely has previously been shown to negatively impact sucrose (Cleary et al., 1996) and self-stimulation (Trujillo et al., 1989) reward in progressive ratio tests. Similarly, mu opioid receptor (Papaleo et al., 2007), beta-endorphin- and enkephalin-knockout mice also show reduced responding for a food reward on a progressive ratio schedule (Hayward et al., 2002).

    • Excitability and gap junction-mediated mechanisms in nucleus accumbens regulate self-stimulation reward in rats

      2009, Neuroscience
      Citation Excerpt :

      Two studies used these antagonists but they were injected intraperitoneally, and thus the effects observed in these studies were attributed to the blockade of peripheral and central opiate receptors. Like in our study, these experiments demonstrated that blockade of opiate receptors results in less self-stimulation (Trujillo et al., 1989a,b). The dopaminergic innervation of the Acb from the ventral tegmental area is an important modulator of the activity in the Acb, and of interest is the dopaminergic modulation of GJC in the striatum, and other brain areas as well (Cepeda et al., 1989; O'Donnell and Grace, 1993; Perez Velazquez et al., 1997).

    • Biological substrates of reward and aversion: A nucleus accumbens activity hypothesis

      2009, Neuropharmacology
      Citation Excerpt :

      The combination of these findings suggests that while dopamine may contribute to reward-related inhibition of NAc firing, there must be other factors that can drive it as well. Although there has been much less investigation of other potential contributors, additional candidates include the release of acetylcholine and the activation of μ-opioid receptors in the NAc, both of which have been shown to occur under rewarding conditions (Trujillo et al., 1989; West and Wise, 1988; Mark et al., 1992; Imperato et al., 1992; Guix et al., 1992; Bodnar et al., 1995; Kelley et al., 1996) and both of which have the ability to inhibit NAc firing (McCarthy et al., 1977; Hakan and Henriksen, 1989; de Rover et al., 2002). Another newer line of electrophysiological evidence supporting the inhibition–reward hypothesis comes from experiments in which molecular approaches have been used to manipulate the excitable properties of NAc neurons.

    • Effect of naltrexone during extinction of alcohol-reinforced responding and during repeated cue-conditioned reinstatement sessions in a cue exposure style treatment

      2008, Alcohol
      Citation Excerpt :

      First, the literature indicates that rats are able to maintain considerable rates of responding for food or fluid after naloxone or NTX doses as high as 30 mg/kg (Sanger and McCarthy, 1982; Schindler et al., 1990; Williams, 2007). In rats responding for electrical brain stimulation, latency to respond was also unaffected by naloxone or NTX doses as high as 20 mg/kg (Trujillo et al., 1989a; 1989b). Second, a direct measurement of ambulatory activity alone shows no effect of naloxone doses up to 10 mg/kg (Timar et al., 2005) and NTX 30 mg/kg has conflicting effects where horizontal activity is reduced but a measure of ambulatory activity is unaffected (Schaefer and Michael, 1985).

    View all citing articles on Scopus

    A preliminary report of this work was presented at the 1984 Society for Neuroscience Meeting in Anaheim, California72.

    View full text